WallStreetZenWallStreetZen

NASDAQ: DYN
Dyne Therapeutics Inc Stock Ownership - Who owns Dyne Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Dyne Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John CoxCEO President2025-06-054,060$13.35
$54.20kSell
Johanna FriedlnadererChief Commercial Officer2025-06-05146$13.35
$1.95kSell
Douglas KerrChief Medical Officer2025-06-051,342$13.35
$17.92kSell
Johanna FriedlnadererChief Commercial Officer2025-03-13143$12.12
$1.73kSell
Richard William ScalzoSVP Head of Finance Admin.2025-03-111,343$11.38
$15.28kSell
Oxana BeskrovnayaChief Scientific Officer2025-03-112,153$11.38
$24.50kSell
Richard William ScalzoSVP Head of Finance Admin.2025-03-05917$11.83
$10.85kSell
Douglas KerrChief Medical Officer2025-03-051,343$11.83
$15.89kSell
Oxana BeskrovnayaChief Scientific Officer2025-03-051,094$11.83
$12.94kSell
John CoxCEO President2025-03-054,061$11.83
$48.04kSell

1 of 15

DYN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DYN insiders and whales buy or sell their stock.

DYN Shareholders

What type of owners hold Dyne Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Janus Henderson Group PLC9.11%10,353,416$149.19MInstitution
Ra Capital Management LP8.55%9,714,392$139.98MInstitution
Atlas Venture Life Science Advisors LLC8.03%9,130,465$131.57MInstitution
Blackrock Inc7.08%8,046,938$115.96MInstitution
Vanguard Group Inc6.52%7,406,344$106.73MInstitution
Atlas Venture Fund XI LP5.77%6,562,578$94.57MInsider
Forbion Capital Fund IV Cooperatief Ua5.39%6,131,079$88.35MInsider
Fcpm III Services Bv4.81%5,462,846$78.72MInstitution
Fmr LLC4.57%5,195,294$74.86MInstitution
Braidwell LP3.19%3,621,344$52.18MInstitution

1 of 3

DYN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DYN79.63%20.37%Net SellingNet Selling
CNTA90.18%9.82%Net SellingNet Buying
EWTX87.08%12.92%Net BuyingNet Buying
ARQT77.02%22.98%Net SellingNet Selling
BHVN82.43%17.57%Net Buying
View Top Biotech Stocks

Dyne Therapeutics Stock Ownership FAQ

Who owns Dyne Therapeutics?

Dyne Therapeutics (NASDAQ: DYN) is owned by 107.20% institutional shareholders, 27.42% Dyne Therapeutics insiders, and 0.00% retail investors. Atlas Venture Fund XI LP is the largest individual Dyne Therapeutics shareholder, owning 6.56M shares representing 5.77% of the company. Atlas Venture Fund XI LP's Dyne Therapeutics shares are currently valued at $94.57M.

If you're new to stock investing, here's how to buy Dyne Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.